| Golden Living Center-indianapolis | |
| 2860 Churchman Ave, Indianapolis, Indiana 46203 | |
| (317) 787-3451 | |
| Name | Golden Living Center-indianapolis |
|---|---|
| Location | 2860 Churchman Ave, Indianapolis, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 115 |
| Occupancy Rate | 59.04% |
| Medicare ID (CCN) | 155138 |
| Legal Business Name | Hendricks County Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1235185810 |
| Organization Name | HENDRICKS COUNTY HOSPITAL |
| Doing Business As | BRICKYARD HEALTHCARE - CHURCHMAN CARE CENTER |
| Address | 2860 Churchman Ave, Indianapolis, IN 46203 |
| Phone Number | 317-787-3451 |
News Archive
The media have widely reported that a debilitating neurological condition called chronic traumatic encephalopathy is a well-established disease in retired athletes who played football and other contact sports.
Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.
Robotic technologies have the potential to help neurosurgeons perform precise, technically demanding operations, together with virtual reality environments to help them navigate through the brain, according to a special supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
› Verified 8 days ago
| NPI Number | 1669915120 |
| Organization Name | DYCORA TRANSITIONAL HEALTH - BEECH GROVE LLC |
| Address | 2860 Churchman Ave, Indianapolis, IN 46203 |
| Phone Number | 317-787-3451 |
News Archive
The media have widely reported that a debilitating neurological condition called chronic traumatic encephalopathy is a well-established disease in retired athletes who played football and other contact sports.
Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.
Robotic technologies have the potential to help neurosurgeons perform precise, technically demanding operations, together with virtual reality environments to help them navigate through the brain, according to a special supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The media have widely reported that a debilitating neurological condition called chronic traumatic encephalopathy is a well-established disease in retired athletes who played football and other contact sports.
Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.
Robotic technologies have the potential to help neurosurgeons perform precise, technically demanding operations, together with virtual reality environments to help them navigate through the brain, according to a special supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $49310 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.03 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.16 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.41 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 11.11 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.9 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 58.33 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.5 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 53.75 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.77 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 11.12 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.81 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 85.2 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 90.63 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 57.09 | 82.93 |
News Archive
The media have widely reported that a debilitating neurological condition called chronic traumatic encephalopathy is a well-established disease in retired athletes who played football and other contact sports.
Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease (RHD) as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation.
Robotic technologies have the potential to help neurosurgeons perform precise, technically demanding operations, together with virtual reality environments to help them navigate through the brain, according to a special supplement to Neurosurgery, official journal of the Congress of Neurological Surgeons.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
› Verified 8 days ago
Community Nursing And Rehabilitation Center Location: 5600 E 16th St, Indianapolis, Indiana 46218 Phone: (317) 356-0911 | |
Northwest Manor Health Care Center Location: 6440 W 34th St, Indianapolis, Indiana 46224 Phone: (317) 293-4930 | |
Golden Living Center-brookview Location: 7145 E 21st Street, Indianapolis, Indiana 46219 Phone: (317) 356-0977 | |
Golden Living Center-indianapolis Location: 2860 Churchman Ave, Indianapolis, Indiana 46203 Phone: (317) 787-3451 |